IMNP @ Stockcharts Without a doubt the whole market is in limbo but with that some buying opportunities...bought more shares today as I look forward to 2017! http://www.marketwatch.com/story/immune-pharmaceuticals-receives-fda-guidance-for-low-dose-il-2-in-combination-with-phase-iii-pivotal-trial-of-its-aml-therapy-ceplene-2016-10-27 investorshub.advfn.com/uimage/uploads/2016/11/4/hykfpsc.png Investor 100